The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response

Biomaterials

Volumn 31, Issue 14, 2010, Pages 3997-4008

  Thevenot, Paul T ^a   Nair, Ashwin M ^a   Shen, Jinhui ^a   Lotfi, Parisa ^a   Ko, Cheng Yu ^a   Tang, Liping ^a  

^a University of Texas at Arlington   (United States)

Author keywords

Angiogenesis; Biocompatibility; Hematopoietic stem cells; Inflammation; Mesenchymal stem cell; Scaffold

Indexed keywords

ANGIOGENESIS; BENEFICIAL EFFECTS; BIOACTIVE COMPONENTS; BIOMATERIAL IMPLANTATION; HEMATOPOIETIC STEM CELLS; IMPLANT INTERFACES; INFLAMMATORY CELLS; INFLAMMATORY RESPONSE; MAST CELLS; MESENCHYMAL STEM CELL; OSMOTIC PUMPS; PLGA SCAFFOLDS; SEEDED CELLS; STEM CELL; TISSUE INTEGRATION; TISSUE RESPONSE;

ADSORPTION; BIOCOMPATIBILITY; CELL CULTURE; CELL PROLIFERATION; EMPLOYMENT; IMPLANTS (SURGICAL); PATHOLOGY; RESPONSE TIME (COMPUTER SYSTEMS); SCAFFOLDS; TISSUE; TISSUE ENGINEERING;

STEM CELLS;

POLYGLACTIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIODEGRADABILITY; CELL COUNT; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CONTROLLED STUDY; FIBROSIS; INFLAMMATION; INFLAMMATORY CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE REPAIR;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; CYTOKINES; FOREIGN-BODY REACTION; HEMATOPOIETIC STEM CELL MOBILIZATION; IMPLANTS, EXPERIMENTAL; INFLAMMATION; LACTIC ACID; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; POLYGLYCOLIC ACID; TISSUE SCAFFOLDS;

EID: 77649275535     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.144     Document Type: Article

References (47)

1. Muschler G.F., Nakamoto C., and Griffith L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A 7 (2004) 1541-1558
2. Silva M.M., Cyster L.A., Barry J.J., Yang X.B., Oreffo R.O., Grant D.M., et al. The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials 27 35 (2006) 5909-5917
3. Jones K.S. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol 20 2 (2008) 130-136
4. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 12 8 (2006) 2093-2104
5. Smith M.K., Peters M.C., Richardson T.P., Garbern J.C., and Mooney D.J. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 10 1-2 (2004) 63-71
6. Seitz S., Ern K., Lamper G., Docheva D., Drosse I., Milz S., et al. Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng 13 5 (2007) 1059-1067
7. Mountziaris P.M., and Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14 2 (2008) 179-186
8. Greco K.V., Lara P.F., Oliveira-Filho R.M., Greco R.V., and Sudo-Hayashi L.S. Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur J Pharmacol 551 1-3 (2006) 131-142
9. Copland I.B., Lord-Dufour S., Cuerquis J., Coutu D., Annabi B., Wang E., et al. Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 27 2 (2009) 467-477
10. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11 7-8 (2005) 1198-1211
11. Mikos A.G., Herring S.W., Ochareon P., Elisseeff J., Lu H.H., Kandel R., et al. Engineering complex tissues. Tissue Eng 12 12 (2006) 3307-3339
12. Vranken I., De Visscher G., Lebacq A., Verbeken E., and Flameng W. The recruitment of primitive Lin(-) Sca-1(+), CD34(+), c-kit(+) and CD271(+) cells during the early intraperitoneal foreign body reaction. Biomaterials 29 7 (2008) 797-808
13. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106 2 (2005) 419-427
14. Zhang G., Nakamura Y., Wang X., Hu Q., Suggs L.J., and Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 13 8 (2007) 2063-2071
15. Thevenot P., Nair A., Dey J., Yang J., and Tang L. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Eng Part C Methods 14 4 (2008) 319-331
16. Nair A., Thevenot P.T., Dey J., Shen J., Sun M.W., Yang J., et al. Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods (2009)
17. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La Rosa S., et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183 2 (2009) 993-1004
18. Tang L., Jennings T.A., and Eaton J.W. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A 95 15 (1998) 8841-8846
19. Nair A., Zou L., Bhattacharyya D., Timmons R.B., and Tang L. Species and density of implant surface chemistry affect the extent of foreign body reactions. Langmuir 24 5 (2008) 2015-2024
20. Gang E.J., Bosnakovski D., Figueiredo C.A., Visser J.W., and Perlingeiro R.C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109 4 (2007) 1743-1751
21. Solovjov D.A., Pluskota E., and Plow E.F. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 280 2 (2005) 1336-1345
22. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 5 (2007) 1801-1809
23. Abramoff, Magelhaes, and Ram. Image processing with imagej. Biophotonics Int 11 7 (2004) 36-42
24. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 1 (2006) 175-189
25. Schledzewski K., Falkowski M., Moldenhauer G., Metharom P., Kzhyshkowska J., Ganss R., et al. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 209 1 (2006) 67-77
26. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 11 (2001) 3354-3360
27. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 21 (2004) 3300-3305
28. Godot V., Arock M., Garcia G., Capel F., Flys C., Dy M., et al. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol 120 4 (2007) 827-834
29. Belot M.P., Abdennebi-Najar L., Gaudin F., Lieberherr M., Godot V., Taieb J., et al. Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors. Am J Physiol Endocrinol Metab 292 5 (2007) E1410-E1417
30. Lin T.J., Issekutz T.B., and Marshall J.S. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol 165 1 (2000) 211-220
31. El-Shazly A., Berger P., Girodet P.-O., Ousova O., Fayon M., Vernejoux J.-M., et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 176 3 (2006) 1860-1868
32. Shimizu T., Owsianik G., Freichel M., Flockerzi V., Nilius B., and Vennekens R. TRPM4 regulates migration of mast cells in mice. Cell Calcium 45 3 (2009) 226-232
33. Pietrzak A., Misiak-Tloczek A., and Brzezinska-Blaszczyk E. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol Lett 123 1 (2009) 46-51
34. Reimold A.M. New indications for treatment of chronic inflammation by TNF-alpha blockade. Am J Med Sci 325 2 (2003) 75-92
35. Dinarello C.A. Proinflammatory cytokines. Chest 118 2 (2000) 503-508
36. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 20 2 (2008) 86-100
37. Thevenot P., Hu W., and Tang L. Surface chemistry influences implant biocompatibility. Curr Top Med Chem 8 4 (2008) 270-280
38. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214 2 (2008) 199-210
39. Landgraeber S, von Knoch M, Löer F, Wegner A, Tsokos M, Hußmann B, et al. Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement. Biomaterials;29(24-25):3444-3450.
40. Hohlbaum A.M., Saff R.R., and Marshak-Rothstein A. Fas-ligand-iron fist or achilles' heel?. Clin Immunol 103 1 (2002) 1-6
41. Xie Y., Gao K., Häkkinen L., and Larjava H.S. Mice lacking β6 integrin in skin show accelerated wound repair in dexamethasone impaired wound healing model. Wound Repair Regen 17 3 (2009) 326-339
42. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12 5 (2006) 557-567
43. Stellos K., Langer H., Daub K., Schoenberger T., Gauss A., Geisler T., et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 117 2 (2008) 206-215
44. Chen L., Tredget E.E., Wu P.Y., and Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 4 (2008) 3 e1886
45. Hosseinkhani H., Hosseinkhani M., Khademhosseini A., Kobayashi H., and Tabata Y. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 27 34 (2006) 5836-5844
46. Hao X., Silva E.A., Mansson-Broberg A., Grinnemo K.-H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75 1 (2007) 178-185
47. Sales V.L., Engelmayr Jr. G.C., Mettler B.A., Johnson Jr. J.A., Sacks M.S., and Mayer Jr. J.E. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation 114 Suppl. 1 (2006) I193-I199